Status:
COMPLETED
Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
University of Bergen
Conditions:
Cognitive Remediation
Cognitive Impairment
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Background: Cognitive impairment and difficulties are frequently observed in individuals suffering from major depressive disorder. These impairments and difficulties can persist into remission as resi...
Detailed Description
Background:Cognitive impairment and difficulties are frequently observed in individuals suffering from major depressive disorder. These impairments and difficulties can persist into remission as resid...
Eligibility Criteria
Inclusion
- Previously received treatment for major depressive disorder in primary or secondary healthcare services
- Reporting a history of major depressive disorder symptoms assess using the MINI. few or minor depression symptomss (\< 12 MADRS)
- Not meeting criteria for major depressive disorder measured by the MINI)
- Self-reporting residual cognitive symptoms that affects daily functioning (assessed by clinical psychologist)
- No changes in anti-depressant medication under the study period
- Age between 18 and 65 years
- Read and write Norwegian
- Internet and telephone access.
Exclusion
- Self-reported substance abuse
- Neurological conditions or damage (e.g. autism, cerebral haemorrhage, and brain tumour)
- Bipolar disorder
- Psychosis.
Key Trial Info
Start Date :
April 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04864353
Start Date
April 26 2021
End Date
April 30 2024
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway